Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03742297
Title Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors PETHEMA Foundation
Indications

multiple myeloma

Therapies

Carfilzomib + Dexamethasone + Lenalidomide

Carfilzomib + Daratumumab + Dexamethasone + Lenalidomide

Bortezomib + Dexamethasone + Lenalidomide + Melphalan + Prednisone

Age Groups: senior
Covered Countries ESP


No variant requirements are available.